Home › Funds › Samsara BioCapital, LLC › ELOX
Samsara BioCapital, LLC position in ELOX
ELOXX PHARMACEUTICALS INC · Health Care
Samsara BioCapital, LLC reported holding 400,000 shares of ELOX (ELOXX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$6.1M, representing 0.58% of its reported portfolio and ranking #21 among its reported holdings. Samsara BioCapital, LLC has disclosed ELOX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Samsara BioCapital, LLC's ELOX position evolved
Samsara BioCapital, LLC first disclosed a stake in ELOX in Q2 2026 at 400,000 shares (US$5.6M). The position peaked in Q3 2026 at 400,000 shares, worth US$6.1M. Across 2 filings, Samsara BioCapital, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 400,000 shares valued at US$6.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 400.00K | $5.55M | New |
| Q3 2026 | 400.00K | $6.12M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELOX and 13F data
ELOX (ELOXX PHARMACEUTICALS INC) is a Health Care company. 19 other funds we track also report a position in ELOX — the largest reported positions include EcoR1 Capital, LLC (US$6.1M), Stonepine Capital Management, LLC (US$5.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELOX
- EcoR1 Capital, LLC 400.00K sh · $6.12M · Q3 2026
- Stonepine Capital Management, LLC 381.98K sh · $5.85M · Q3 2026
More on Samsara BioCapital, LLC
FAQ
How long has Samsara BioCapital, LLC held ELOX?
Samsara BioCapital, LLC has disclosed ELOX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Samsara BioCapital, LLC's current position in ELOX?
As of Q3 2026, Samsara BioCapital, LLC holds 400.00K shares of ELOX (ELOXX PHARMACEUTICALS INC), valued at $6.12M, representing 0.58% of its reported portfolio and ranking #21.
Has Samsara BioCapital, LLC been buying or selling ELOX?
In the latest 13F filing (Q3 2026), Samsara BioCapital, LLC held unchanged its position in ELOX. The position peaked in Q3 2026 at 400.00K shares.
Which other funds hold ELOX?
Other major institutional holders of ELOX include EcoR1 Capital, LLC, Stonepine Capital Management, LLC, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.